Protein degradation: proteases and protease inhibitors
In healthy cells and organisms the balance between protein production and degradation is of crucial importance. Proteins are degraded by proteolytic enzymes (proteases). They are classified in five major classes based on the specific chemical groups responsible for the catalysis (serine-, cysteine-, aspartic-, threonine-and metallo-proteases). 1 Most proteases are relatively nonspecific for substrates but some of them show specificity toward a single peptide bond of a particular protein. The complete set of proteases produced by human cells consists of at least 569 proteases and homologues distributed into these five classes. 2 The action of proteases is tightly controlled by a powerful regulatory system. A crucial role in the regulation of protease activity is exerted by endogenous protease inhibitors. They protect cells and tissues against the proteolytic activity of proteases that are often secreted by or released from normal dying cells or in pathologic situations such as tumor progression. 3 Endogenous inhibitors are always proteins but their number is much lower than that of proteases. One of the systems used to classify these inhibitors is based on the catalytic class of proteases they target.
Another critical component of the protein degradation machinery is the ubiquitin-proteasome system (UPS), which operates both in the nucleus and in the cytosol. 4 UPS consists of a large number of proteins that are dedicated to the identification, targeting and destruction of unneeded or damaged proteins by proteolysis. Proteins are tagged for degradation by a small protein (8.5 kDa) called ubiquitin. This is a multistep process that involves at least three classes of enzymes generally known as ubiquitinating enzymes (UBs): ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2) and ubiquitin protein ligases (E3). In addition, deubiquitinating enzymes (DUBs) also play a crucial role regulating this process. 5 The proteasome contains a barrel-shaped proteolytic core complex (the proteasome 20S) Protease M is a member of the kallikrein (KLK) family, which includes secreted serine proteases with a wide-range of expression that are commonly regulated by steroid hormones in several cancer cell lines. 41 The induction of protease M after 1,25(OH) 2 D 3 treatment was confirmed by Northern blotting and immunofluorescence. 20, 22 We also found that, similarly to protease M, normal epithelial cell-specific 1 (NES1), another member of the kallikrein family (KLK-10), was induced by 1,25(OH) 2 D 3 in SW480-ADH human colon cancer cells. This result was confirmed by Northern blot. 22 Data from our laboratory also revealed that KLK-7 RNA expression is induced 9.5-fold by 
Vitamin D and the ubiquitin-proteasome system
The ubiquitin-proteasome system (UPS) has been implicated in cancer and chemotherapy action. 4, 43 The rationale behind this is the control by the UPS of transcription factors and components of the apoptotic machinery that play important roles in the control of cell phenotype and survival. The clinical use of the proteasome inhibitor Bortezomib (Velcade®) against multiple myeloma is a proof-of-concept.
Transcriptomic analyses using human SW480-ADH colon cancer cells performed in our laboratory have revealed numerous UPS genes as candidate targets of 1,25(OH) 2 D 3 (Table I) . These genes include a group encoding ubiquitinating (UBs) and deubiquitinating (DUBs) enzymes and another group corresponding to components of the proteasome particle. The effect observed is an almost general repression of these genes at 48 h of 1,25(OH) 2 D 3 treatment. This could be related to the antitumoral action of the hormone, as cancer cells have higher level of proteasome activity than their normal counterparts. 4 Ubiquitin-mediated events are critical for cell function and proliferation, and the association of DUBs with cancer is increasingly recognized. 44 The list of transcription factors regulated by the UPS includes both oncogenes and tumor suppressor genes. The protease inhibitor cystatin D is induced by 1,25(OH) 2 D 3 and mediates, at least partially, its antitumor activity in colon cancer by cathepsin inhibition-dependent andindependent mechanisms (see ref. 26 for a detailed description).
